Funding for this research was provided by:
the National Key R&D Program of China (2017YFC1307600)
Liaoning science and technology project, Research and demonstration of hypertension diagnosis and treatment and optimization of process management in Liaoning Province community (2017107001)
Article History
Received: 12 March 2020
Accepted: 5 November 2020
First Online: 12 November 2020
Ethics approval and consent to participate
: The study was granted approval by the Central Ethics Committee at the China National Center for Cardiovascular Disease. Written informed consent from all participants was obtained.
: Not applicable.
: The authors declare that they have no competing interests.